Keyphrases
Chronic Obstructive Pulmonary Disease
100%
Statin Drugs
100%
Disease-specific Outcomes
100%
Statins
50%
Adjusted Odds Ratio
25%
Confidence Interval
25%
Hospitalization
25%
Newly Diagnosed
25%
Statin Therapy
25%
Emergency Room Visits
25%
Outpatient Visits
25%
Disease-specific
16%
Inverse Probability
16%
Clinical Trials
8%
Longitudinal Dynamics
8%
Multivariable Logistic Regression
8%
Low Dose Rate
8%
Selection Bias
8%
Statin Use
8%
Beneficial Effects
8%
Primary Diagnosis
8%
Anti-inflammatory Properties
8%
Prescription Drugs
8%
Baseline Period
8%
Medicaid Claims Data
8%
Disease-modifying Therapy
8%
HMG-CoA Reductase Inhibitors
8%
Pharmacology, Toxicology and Pharmaceutical Science
Observational Study
100%
Statin (Protein)
100%
Chronic Obstructive Lung Disease
100%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
58%
Clinical Trial
8%
Anti-Inflammatory Drug
8%
Cohort Study
8%
Prescription Drug
8%
Diseases
8%
Neuroscience
Statin
100%
Chronic Obstructive Pulmonary Disease
100%
Anti-Inflammatory
8%